1094 related articles for article (PubMed ID: 17351403)
21. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
[TBL] [Abstract][Full Text] [Related]
22. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
Metzger E; Friedman R
J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
[TBL] [Abstract][Full Text] [Related]
23. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
[TBL] [Abstract][Full Text] [Related]
24. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
[TBL] [Abstract][Full Text] [Related]
25. [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol].
Guy JM; André-Fouet X; Porte J; Bertrand M; Lamaud M; Verneyre H
Ann Cardiol Angeiol (Paris); 1991 Nov; 40(9):541-5. PubMed ID: 1776799
[TBL] [Abstract][Full Text] [Related]
26. Torsades de pointes and long QT syndromes.
Janeira LF
Am Fam Physician; 1995 Oct; 52(5):1447-53. PubMed ID: 7572567
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
28. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
30. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
[TBL] [Abstract][Full Text] [Related]
31. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
Amankwa K; Krishnan SC; Tisdale JE
Clin Pharmacol Ther; 2004 Mar; 75(3):242-7. PubMed ID: 15001976
[TBL] [Abstract][Full Text] [Related]
32. Long-QT syndrome and torsades de pointes in a patient with Takotsubo cardiomyopathy: an unusual case.
Mahida S; Dalageorgou C; Behr ER
Europace; 2009 Mar; 11(3):376-8. PubMed ID: 19095686
[TBL] [Abstract][Full Text] [Related]
33. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
34. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
Zeltser D; Justo D; Halkin A; Prokhorov V; Heller K; Viskin S
Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
[TBL] [Abstract][Full Text] [Related]
35. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
Glassman AH
J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
[TBL] [Abstract][Full Text] [Related]
36. Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers.
Milberg P; Fleischer D; Stypmann J; Osada N; Mönnig G; Engelen MA; Bruch C; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2007 Jan; 102(1):42-51. PubMed ID: 16817026
[TBL] [Abstract][Full Text] [Related]
37. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Ly T; Ruiz ME
Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
[TBL] [Abstract][Full Text] [Related]
38. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
Gury C; Canceil O; Iaria P
Encephale; 2000; 26(6):62-72. PubMed ID: 11217540
[TBL] [Abstract][Full Text] [Related]
39. Erythromycin induced torsades de pointes.
Wong CB; Windle J
Nebr Med J; 1995 Sep; 80(9):285-6. PubMed ID: 7566254
[TBL] [Abstract][Full Text] [Related]
40. [Extension of QT interval as a consequence of risk factor accumulation--case study].
Sisáková M; Toman O; Floriánová A; Kadlecová J; Chroust K; Papousek I; Spinar J
Vnitr Lek; 2006 Mar; 52(3):271-3. PubMed ID: 16722159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
